What Is Quality by Design in Pharmaceutical Development?UntitledA Skills-First Approach for Saudi Teams
Quality by Design Training in Saudi Arabia introduces Quality by Design (QbD), a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into the product from the design stage rather than testing it in at the end. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines, the course shows how the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, Design of Experiments (DoE), the design space and the Control Strategy work together to deliver consistent quality. As the Kingdom scales local manufacturing under Vision 2030 and the SFDA aligns inspection with PIC/S and ICH expectations, QbD fluency is fast becoming a baseline expectation for development, quality and regulatory teams. This programme suits formulation scientists, analytical scientists, process development engineers, QA professionals and CMC regulatory specialists across pharma, biopharma and CDMO organisations. You leave able to apply QbD tools to real development scenarios and to structure QbD evidence for regulatory submissions. Start your QbD journey with Invensis Learning and turn ICH principles into everyday practice.










